The Medicines and Healthcare products Regulatory Agency (MHRA) has approved a change to the license of the Comirnaty Omicron XBB.1.5 30 micrograms/dose (single-dose vials) after it was found to meet the UK regulator’s standards of safety, quality and effectiveness.
Bavarian Nordic shares sink by 12% after mpox sales slump in Q3 – Pharmaceutical Technology
Bavarian Nordic said quarterly and annual comparisons are challenging due to the dynamic nature of outbreaks and order size. Image credit: Shutterstock/Sonia Bonet. Bavarian Nordic